ALK and cancer: Given that genetic fusions have been previously noted to exhibit tissue specificity, such as ETV family fusions in prostate cancer7 and ALK or MET fusions in lung cancer8,9,14, we hypothesized that inclusion of cancer type-specificity would likely improve our statistical power.